nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Eosinophilia—Auranofin—psoriatic arthritis	0.034	0.034	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Auranofin—psoriatic arthritis	0.0321	0.0321	CcSEcCtD
Ceftaroline fosamil—Anaemia—Auranofin—psoriatic arthritis	0.0221	0.0221	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Auranofin—psoriatic arthritis	0.0191	0.0191	CcSEcCtD
Ceftaroline fosamil—Constipation—Auranofin—psoriatic arthritis	0.0167	0.0167	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.016	0.016	CcSEcCtD
Ceftaroline fosamil—Urticaria—Auranofin—psoriatic arthritis	0.0155	0.0155	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Auranofin—psoriatic arthritis	0.0154	0.0154	CcSEcCtD
Ceftaroline fosamil—Pruritus—Auranofin—psoriatic arthritis	0.0138	0.0138	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Auranofin—psoriatic arthritis	0.0134	0.0134	CcSEcCtD
Ceftaroline fosamil—Vomiting—Auranofin—psoriatic arthritis	0.0124	0.0124	CcSEcCtD
Ceftaroline fosamil—Rash—Auranofin—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Auranofin—psoriatic arthritis	0.0123	0.0123	CcSEcCtD
Ceftaroline fosamil—Nausea—Auranofin—psoriatic arthritis	0.0116	0.0116	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00963	0.00963	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00963	0.00963	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00896	0.00896	CcSEcCtD
Ceftaroline fosamil—Infestation—Methylprednisolone—psoriatic arthritis	0.00896	0.00896	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisolone—psoriatic arthritis	0.00893	0.00893	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Prednisone—psoriatic arthritis	0.00838	0.00838	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00825	0.00825	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00825	0.00825	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Triamcinolone—psoriatic arthritis	0.00821	0.00821	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00819	0.00819	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisolone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Dexamethasone—psoriatic arthritis	0.00745	0.00745	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Betamethasone—psoriatic arthritis	0.00745	0.00745	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Prednisone—psoriatic arthritis	0.00744	0.00744	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methylprednisolone—psoriatic arthritis	0.0073	0.0073	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00727	0.00727	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00718	0.00718	CcSEcCtD
Ceftaroline fosamil—Erythema—Triamcinolone—psoriatic arthritis	0.00702	0.00702	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methylprednisolone—psoriatic arthritis	0.007	0.007	CcSEcCtD
Ceftaroline fosamil—Erythema—Methylprednisolone—psoriatic arthritis	0.007	0.007	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Betamethasone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Dexamethasone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisolone—psoriatic arthritis	0.00661	0.00661	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Methotrexate—psoriatic arthritis	0.00659	0.00659	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Prednisone—psoriatic arthritis	0.00649	0.00649	CcSEcCtD
Ceftaroline fosamil—Erythema—Betamethasone—psoriatic arthritis	0.00637	0.00637	CcSEcCtD
Ceftaroline fosamil—Erythema—Dexamethasone—psoriatic arthritis	0.00637	0.00637	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Methotrexate—psoriatic arthritis	0.00622	0.00622	CcSEcCtD
Ceftaroline fosamil—Convulsion—Triamcinolone—psoriatic arthritis	0.00608	0.00608	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methylprednisolone—psoriatic arthritis	0.00607	0.00607	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Methotrexate—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Ceftaroline fosamil—Infestation—Methotrexate—psoriatic arthritis	0.00593	0.00593	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00592	0.00592	CcSEcCtD
Ceftaroline fosamil—Renal failure—Methotrexate—psoriatic arthritis	0.00583	0.00583	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Prednisone—psoriatic arthritis	0.00578	0.00578	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Prednisone—psoriatic arthritis	0.00576	0.00576	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00573	0.00573	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00572	0.00572	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00561	0.00561	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00561	0.00561	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Ceftaroline fosamil—Erythema—Prednisone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Prednisone—psoriatic arthritis	0.00555	0.00555	CcSEcCtD
Ceftaroline fosamil—Convulsion—Dexamethasone—psoriatic arthritis	0.00552	0.00552	CcSEcCtD
Ceftaroline fosamil—Convulsion—Betamethasone—psoriatic arthritis	0.00552	0.00552	CcSEcCtD
Ceftaroline fosamil—Pain—Prednisolone—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Methotrexate—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00526	0.00526	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Methotrexate—psoriatic arthritis	0.00522	0.00522	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0052	0.0052	CcSEcCtD
Ceftaroline fosamil—Anaemia—Prednisone—psoriatic arthritis	0.00513	0.00513	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Betamethasone—psoriatic arthritis	0.0051	0.0051	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00509	0.00509	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisolone—psoriatic arthritis	0.00495	0.00495	CcSEcCtD
Ceftaroline fosamil—Pain—Triamcinolone—psoriatic arthritis	0.0049	0.0049	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Methotrexate—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Methotrexate—psoriatic arthritis	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Convulsion—Prednisone—psoriatic arthritis	0.00481	0.00481	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00469	0.00469	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00467	0.00467	CcSEcCtD
Ceftaroline fosamil—Erythema—Methotrexate—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Methotrexate—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00459	0.00459	CcSEcCtD
Ceftaroline fosamil—Urticaria—Triamcinolone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methylprednisolone—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Ceftaroline fosamil—Pain—Dexamethasone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Pain—Betamethasone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Prednisone—psoriatic arthritis	0.00444	0.00444	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Prednisone—psoriatic arthritis	0.0044	0.0044	CcSEcCtD
Ceftaroline fosamil—Anaemia—Methotrexate—psoriatic arthritis	0.00428	0.00428	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00422	0.00422	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Ceftaroline fosamil—Urticaria—Dexamethasone—psoriatic arthritis	0.00413	0.00413	CcSEcCtD
Ceftaroline fosamil—Urticaria—Betamethasone—psoriatic arthritis	0.00413	0.00413	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisolone—psoriatic arthritis	0.00412	0.00412	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Betamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Betamethasone—psoriatic arthritis	0.00411	0.00411	CcSEcCtD
Ceftaroline fosamil—Pruritus—Triamcinolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methylprednisolone—psoriatic arthritis	0.00404	0.00404	CcSEcCtD
Ceftaroline fosamil—Convulsion—Methotrexate—psoriatic arthritis	0.00402	0.00402	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisolone—psoriatic arthritis	0.00393	0.00393	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisolone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00391	0.00391	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisolone—psoriatic arthritis	0.0039	0.0039	CcSEcCtD
Ceftaroline fosamil—Constipation—Prednisone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Ceftaroline fosamil—Dizziness—Triamcinolone—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methylprednisolone—psoriatic arthritis	0.00378	0.00378	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisolone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Ceftaroline fosamil—Pruritus—Dexamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Pruritus—Betamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Methotrexate—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Ceftaroline fosamil—Vomiting—Triamcinolone—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methylprednisolone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Ceftaroline fosamil—Rash—Triamcinolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Triamcinolone—psoriatic arthritis	0.00361	0.00361	CcSEcCtD
Ceftaroline fosamil—Rash—Methylprednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methylprednisolone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Urticaria—Prednisone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Ceftaroline fosamil—Headache—Triamcinolone—psoriatic arthritis	0.00359	0.00359	CcSEcCtD
Ceftaroline fosamil—Headache—Methylprednisolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Prednisone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Betamethasone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Ceftaroline fosamil—Dizziness—Dexamethasone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Dizziness—Betamethasone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Ceftaroline fosamil—Nausea—Triamcinolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Ceftaroline fosamil—Nausea—Methylprednisolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Prednisone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dexamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Vomiting—Betamethasone—psoriatic arthritis	0.00331	0.00331	CcSEcCtD
Ceftaroline fosamil—Rash—Dexamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Ceftaroline fosamil—Rash—Betamethasone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Betamethasone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Dexamethasone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Ceftaroline fosamil—Headache—Dexamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Ceftaroline fosamil—Headache—Betamethasone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Ceftaroline fosamil—Pain—Methotrexate—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Ceftaroline fosamil—Pruritus—Prednisone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Prednisone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Ceftaroline fosamil—Nausea—Dexamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Ceftaroline fosamil—Nausea—Betamethasone—psoriatic arthritis	0.00309	0.00309	CcSEcCtD
Ceftaroline fosamil—Urticaria—Methotrexate—psoriatic arthritis	0.00301	0.00301	CcSEcCtD
Ceftaroline fosamil—Dizziness—Prednisone—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Methotrexate—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Methotrexate—psoriatic arthritis	0.00299	0.00299	CcSEcCtD
Ceftaroline fosamil—Vomiting—Prednisone—psoriatic arthritis	0.00288	0.00288	CcSEcCtD
Ceftaroline fosamil—Rash—Prednisone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Prednisone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Ceftaroline fosamil—Headache—Prednisone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Ceftaroline fosamil—Nausea—Prednisone—psoriatic arthritis	0.00269	0.00269	CcSEcCtD
Ceftaroline fosamil—Pruritus—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Methotrexate—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Ceftaroline fosamil—Dizziness—Methotrexate—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Ceftaroline fosamil—Vomiting—Methotrexate—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Rash—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Methotrexate—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Ceftaroline fosamil—Headache—Methotrexate—psoriatic arthritis	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Nausea—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
